SELLAS Life Sciences SLS
NASDAQ SLS
$11.88 +0.55 (+4.85%)
As of: Oct 2, 2026 · 10:30 AM EDT

SELLAS Life Sciences (SLS) Return on Assets [ROA] (2011 - 2026)

Updated

SELLAS Life Sciences' Return on Assets [ROA] came in at -27.14% for Q2 2026, up 53.69 percentage points from -80.83% a year earlier and up 5.55 percentage points from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, SELLAS Life Sciences' Return on Assets [ROA] was -57.83%, up 187.87 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of -4.35 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -245.71% in FY2024 (+33.13 pp), -278.84% in FY2023 (-103.90 pp), -174.94% in FY2022 (-117.70 pp) and -57.24% in FY2021 (-3.75 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Assets [ROA] since Q3 2016.
  • Year-over-year, Return on Assets [ROA] has increased for eight consecutive quarters, with an average year-over-year change of +133.49 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q4 2024 (a gain of 392.25 percentage points), and the weakest in Q4 2023 (a drop of 350.73 percentage points).
  • Business Quant data shows SLS's Return on Assets [ROA] at -32.69% (Q1 2026), -43.53% (Q4 2025) and -64.24% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 SELLAS Life Sciences 2.49 Bn 2.49 Bn - -27.14%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.14%
Mar 31, 2026 -32.69%
Dec 31, 2025 -43.53%
Sep 30, 2025 -64.24%
Jun 30, 2025 -80.83%
Mar 31, 2025 -102.71%
Dec 31, 2024 -137.20%
Sep 30, 2024 -157.47%
Jun 30, 2024 -175.99%
Mar 31, 2024 -236.41%
Dec 31, 2023 -529.45%
Sep 30, 2023 -293.70%
Jun 30, 2023 -154.91%
Mar 31, 2023 -145.85%
Dec 31, 2022 -178.72%
Sep 30, 2022 -151.60%
Jun 30, 2022 -163.87%
Mar 31, 2022 -166.78%
Dec 31, 2021 -78.76%
Sep 30, 2021 -43.72%
API Access

SELLAS Life Sciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SLS&period=max&api_key=YOUR_API_KEY